X4 Pharmaceuticals (XFOR) Insider Trading & Ownership $0.51 +0.05 (+10.06%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends X4 Pharmaceuticals (NASDAQ:XFOR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.62%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$491,874.90 Get XFOR Insider Trade Alerts Want to know when executives and insiders are buying or selling X4 Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XFOR Insider Buying and Selling by Quarter X4 Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/15/2024Paula RaganCEOSell31,897$0.56$17,862.32 10/7/2024Adam S. MostafaCFOSell230,645$0.55$126,854.75 10/7/2024Mark BaldryInsiderSell11,127$0.58$6,453.66 10/7/2024Mary DibiaseCOOSell67,695$0.57$38,586.15 10/7/2024Paula RaganCEOSell239,436$0.55$131,689.80 3/11/2024Adam S. MostafaCFOSell52,500$0.88$46,200.00 3/11/2024Arthur TaverasInsiderSell14,235$0.88$12,526.80 3/11/2024Mary DibiaseCOOSell15,409$0.88$13,559.92 3/11/2024Paula RaganCEOSell49,678$0.88$43,716.64 2/12/2024Adam S MostafaCFOSell27,721$1.01$27,998.21 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/12/2024Arthur TaverasInsiderSell787$1.01$794.87 2/12/2024Mary DibiaseCOOSell3,683$1.01$3,719.83 2/12/2024Paula RaganCEOSell21,695$1.01$21,911.95 (Data available from 1/1/2013 forward) XFOR Insider Trading Activity - Frequently Asked Questions Who is on X4 Pharmaceuticals's Insider Roster? The list of insiders at X4 Pharmaceuticals includes Adam S Mostafa, Arthur Taveras, Israel Niv, Mark Baldry, Mary Dibiase, Michael S Wyzga, Murray Stewart, Paula Ragan, and Tuvia Barlev. Learn more on insiders at XFOR. What percentage of X4 Pharmaceuticals stock is owned by insiders? 1.62% of X4 Pharmaceuticals stock is owned by insiders. Learn more on XFOR's insider holdings. Which X4 Pharmaceuticals insiders have been buying company stock? The following insider purchased XFOR shares in the last 24 months: Michael S Wyzga ($30,000.00). How much insider buying is happening at X4 Pharmaceuticals? Insiders have purchased a total of 25,000 XFOR shares in the last 24 months for a total of $30,000.00 bought. Which X4 Pharmaceuticals insiders have been selling company stock? The following insiders have sold XFOR shares in the last 24 months: Adam S Mostafa ($249,621.63), Arthur Taveras ($14,184.71), Israel Niv ($1,401.04), Mark Baldry ($13,941.27), Mary Dibiase ($117,071.47), Murray Stewart ($137,859.36), Paula Ragan ($457,104.09), and Tuvia Barlev ($6,995.24). How much insider selling is happening at X4 Pharmaceuticals? Insiders have sold a total of 1,539,854 X4 Pharmaceuticals shares in the last 24 months for a total of $1,171,233.56 sold. X4 Pharmaceuticals Key ExecutivesDr. Paula Ragan Ph.D. (Age 54)CEO, President & Director Compensation: $1.01MMr. Adam S. Mostafa (Age 44)CFO, Treasurer & Corporate Secretary Compensation: $700.78k1 recent tradesDr. Christophe Arbet-Engels M.B.A. (Age 62)M.D., Ph.D., Chief Medical Officer Compensation: $379.8kDr. Richard Peters M.D. (Age 61)Ph.D., Founder Dr. Renato T. Skerlj Ph.D.FounderDr. Keith T. Flaherty M.D. (Age 53)Founder & Member of Corporate Advisory Board Dr. Mary DiBiase Ph.D. (Age 63)Chief Operating Officer Compensation: $661.59kDr. Arthur Taveras Ph.D. (Age 60)Chief Scientific Officer Dr. Robert David Arbeit (Age 76)Senior Vice President of Clinical Development and Translational Research Mr. Mark Baldry M.B.A. (Age 60)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Organogenesis Insider Ownership Aura Biosciences Insider Ownership KalVista Pharmaceuticals Insider Ownership Eton Pharmaceuticals Insider Ownership Taysha Gene Therapies Insider Ownership Prime Medicine Insider Ownership Monte Rosa Therapeutics Insider Ownership Korro Bio Insider Ownership Revance Therapeutics Insider Ownership REGENXBIO Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:XFOR) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share X4 Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
